indiamed
  • News
  • Opinion
  • Interviews
  • IT
  • Finance
  • Strategy
    • Innovation
  • Ophthalmology
  • News
  • Opinion
  • Interviews
  • IT
  • Finance
  • Strategy
    • Innovation
  • Ophthalmology
facebook x icon x icon linkedin linkedin
all-news

Gleneagles Hospital Chennai Hosts GLENONCON 2025

IMT News Desk

Over 300 doctors and multidisciplinary experts in Chennai participated in the conference

Gleneagles Hospital Chennai hosted its one-day oncology conference GLENONCON 2025, bringing together over 300 delegates from across Chennai and Tamil Nadu. The conference was inaugurated by Dr. J Radhakrishnan, Additional Chief Secretary and CMD, Tamil Nadu Electricity Board, in the presence of Dr Biswarup Pal, Chief of Operations and Medical Services, Gleneagles Hospital Chennai; Dr Balaji Ramani, Director, Gleneagles Institute of Oncology and eminent clinicians and senior healthcare leaders.

The event served as a dynamic platform for oncologists, surgeons, researchers, and healthcare professionals to exchange knowledge and deliberate on cutting-edge developments in cancer care. With an extensive and distinguished faculty, the conference reflected Gleneagles Hospital  commitment to advancing oncology through collaboration and innovation.

Dr Nageswar Rao K, Cluster CEO, Chennai and Hyderabad, Gleneagles Hospitals, highlighting about GLEN ONCON 2025 said, “At Gleneagles, our vision goes beyond delivering advanced treatment. It is also about creating spaces for dialogue, learning, and innovation. GLEN ONCON 2025 embodies this spirit, where leading experts come together to share insights that ultimately translate into better outcomes for patients and stronger healthcare systems.”

Dr Balaji Ramani, Director, Oncology, Gleneagles Hospital Chennai and Organising Chairman of GLEN ONCON 2025, pointed out, “This year’s conference has brought together more than 40 eminent specialists across oncology, neurosurgery, radiation therapy, endocrinology, and allied specialties. Sessions focused on advanced cancer surgery, robotic oncology, head & neck oncology, radiation therapy, and supportive care. Such multidisciplinary engagement reinforces our mission to push the frontiers of cancer care and ensure that every patient has access to the latest knowledge and innovations.”

Recommended

Fortis Nagarbhavi unveils next generation Mako Robotic Technology for knee joint replacements

Novo Nordisk launches Ozempic in India

Aster DM Healthcare announces Rs 120 Cr commitment for Oncology Radiation LINAC Centres

Improving breast cancer treatment in India: Early detection, empowering patients and the potential of innovation

‘Reading the mind of cancer’: Indian researchers build AI tool OncoMark to predict tumour behaviour

J&J, Asia Pacific Patient Advocacy Group leaders unite to strengthen shared decision-making in lung cancer care

Bengaluru-based Maarga Mind Care expands to Gurgaon

Johns Hopkins University collaborates with Great Learning to launch AI in healthcare prog

Indiamedtoday

A premier media platform empowering healthcare professionals with critical business insights, news, and innovations to excel in a rapidly evolving industry.

EMAIL editorial@indiamedtoday.com

EMAIL sales@indiamedtoday.com

quick links

news health it interview opinion strategy magazine privacy policy terms and conditions

subscribe to our newsletter

Stay updated with the latest breakthroughs in Indian healthcare, medical research, and wellness insights.

    follow us

    facebook x icon x icon linkedin linkedin
    Copyright © 2025 INDIAMED TODAY Marketed By Screetract Solutions